Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations
• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale.
Autor*in: |
Smith, Laramie R. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
---|
Umfang: |
10 |
---|
Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:162 ; year:2016 ; day:1 ; month:05 ; pages:34-43 ; extent:10 |
Links: |
---|
DOI / URN: |
10.1016/j.drugalcdep.2016.02.019 |
---|
Katalog-ID: |
ELV019395930 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV019395930 | ||
003 | DE-627 | ||
005 | 20230623150916.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.drugalcdep.2016.02.019 |2 doi | |
028 | 5 | 2 | |a GBVA2016012000009.pica |
035 | |a (DE-627)ELV019395930 | ||
035 | |a (ELSEVIER)S0376-8716(16)00094-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 44.39 |2 bkl | ||
100 | 1 | |a Smith, Laramie R. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
264 | 1 | |c 2016 | |
300 | |a 10 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. | ||
650 | 7 | |a Substance use |2 Elsevier | |
650 | 7 | |a Substance abuse treatment |2 Elsevier | |
650 | 7 | |a Measures |2 Elsevier | |
650 | 7 | |a Stigma |2 Elsevier | |
650 | 7 | |a Psychometrics |2 Elsevier | |
650 | 7 | |a Substance disorder |2 Elsevier | |
700 | 1 | |a Earnshaw, Valerie A. |4 oth | |
700 | 1 | |a Copenhaver, Michael M. |4 oth | |
700 | 1 | |a Cunningham, Chinazo O. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
773 | 1 | 8 | |g volume:162 |g year:2016 |g day:1 |g month:05 |g pages:34-43 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2016.02.019 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
936 | b | k | |a 44.39 |j Toxikologie |q VZ |
951 | |a AR | ||
952 | |d 162 |j 2016 |b 1 |c 0501 |h 34-43 |g 10 | ||
953 | |2 045F |a 610 |
author_variant |
l r s lr lrs |
---|---|
matchkey_str |
smithlaramierearnshawvalerieacopenhaverm:2016----:usacuetgaeibltadaiiyfterbsdclfr |
hierarchy_sort_str |
2016 |
bklnumber |
44.38 44.39 |
publishDate |
2016 |
allfields |
10.1016/j.drugalcdep.2016.02.019 doi GBVA2016012000009.pica (DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Smith, Laramie R. verfasserin aut Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier Earnshaw, Valerie A. oth Copenhaver, Michael M. oth Cunningham, Chinazo O. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 https://doi.org/10.1016/j.drugalcdep.2016.02.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 162 2016 1 0501 34-43 10 045F 610 |
spelling |
10.1016/j.drugalcdep.2016.02.019 doi GBVA2016012000009.pica (DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Smith, Laramie R. verfasserin aut Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier Earnshaw, Valerie A. oth Copenhaver, Michael M. oth Cunningham, Chinazo O. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 https://doi.org/10.1016/j.drugalcdep.2016.02.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 162 2016 1 0501 34-43 10 045F 610 |
allfields_unstemmed |
10.1016/j.drugalcdep.2016.02.019 doi GBVA2016012000009.pica (DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Smith, Laramie R. verfasserin aut Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier Earnshaw, Valerie A. oth Copenhaver, Michael M. oth Cunningham, Chinazo O. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 https://doi.org/10.1016/j.drugalcdep.2016.02.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 162 2016 1 0501 34-43 10 045F 610 |
allfieldsGer |
10.1016/j.drugalcdep.2016.02.019 doi GBVA2016012000009.pica (DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Smith, Laramie R. verfasserin aut Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier Earnshaw, Valerie A. oth Copenhaver, Michael M. oth Cunningham, Chinazo O. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 https://doi.org/10.1016/j.drugalcdep.2016.02.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 162 2016 1 0501 34-43 10 045F 610 |
allfieldsSound |
10.1016/j.drugalcdep.2016.02.019 doi GBVA2016012000009.pica (DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Smith, Laramie R. verfasserin aut Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier Earnshaw, Valerie A. oth Copenhaver, Michael M. oth Cunningham, Chinazo O. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 https://doi.org/10.1016/j.drugalcdep.2016.02.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 162 2016 1 0501 34-43 10 045F 610 |
language |
English |
source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 |
sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:162 year:2016 day:1 month:05 pages:34-43 extent:10 |
format_phy_str_mv |
Article |
bklname |
Pharmakologie Toxikologie |
institution |
findex.gbv.de |
topic_facet |
Substance use Substance abuse treatment Measures Stigma Psychometrics Substance disorder |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Statistical analysis to identify biomarkers for safety |
authorswithroles_txt_mv |
Smith, Laramie R. @@aut@@ Earnshaw, Valerie A. @@oth@@ Copenhaver, Michael M. @@oth@@ Cunningham, Chinazo O. @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV000553670 |
dewey-sort |
3610 |
id |
ELV019395930 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395930</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.02.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395930</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00094-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Smith, Laramie R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance abuse treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Measures</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stigma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychometrics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Earnshaw, Valerie A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Copenhaver, Michael M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cunningham, Chinazo O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:34-43</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.02.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">34-43</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Smith, Laramie R. |
spellingShingle |
Smith, Laramie R. ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
authorStr |
Smith, Laramie R. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder Elsevier |
topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder |
topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder |
topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Substance abuse treatment Elsevier Measures Elsevier Stigma Elsevier Psychometrics Elsevier Substance disorder |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
v a e va vae m m c mm mmc c o c co coc |
hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
hierarchy_parent_id |
ELV000553670 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000553670 |
title |
Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
ctrlnum |
(DE-627)ELV019395930 (ELSEVIER)S0376-8716(16)00094-6 |
title_full |
Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
author_sort |
Smith, Laramie R. |
journal |
Statistical analysis to identify biomarkers for safety |
journalStr |
Statistical analysis to identify biomarkers for safety |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
34 |
author_browse |
Smith, Laramie R. |
container_volume |
162 |
physical |
10 |
class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Smith, Laramie R. |
doi_str_mv |
10.1016/j.drugalcdep.2016.02.019 |
dewey-full |
610 |
title_sort |
substance use stigma: reliability and validity of a theory-based scale for substance-using populations |
title_auth |
Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
abstract |
• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. |
abstractGer |
• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. |
abstract_unstemmed |
• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
title_short |
Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations |
url |
https://doi.org/10.1016/j.drugalcdep.2016.02.019 |
remote_bool |
true |
author2 |
Earnshaw, Valerie A. Copenhaver, Michael M. Cunningham, Chinazo O. |
author2Str |
Earnshaw, Valerie A. Copenhaver, Michael M. Cunningham, Chinazo O. |
ppnlink |
ELV000553670 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.drugalcdep.2016.02.019 |
up_date |
2024-07-06T21:20:33.756Z |
_version_ |
1803866167056531456 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395930</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.02.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395930</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00094-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Smith, Laramie R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The current study evaluates a novel theory-based substance use stigma scale. • Generalizability of responses was observed in two independent diverse substance-using samples. • Results supports the validity and reliability of the substance use stigma scale.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance abuse treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Measures</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stigma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychometrics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Earnshaw, Valerie A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Copenhaver, Michael M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cunningham, Chinazo O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:34-43</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.02.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">34-43</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4019423 |